The most up to date reporting and breakthroughs in anal cancer and HPV research, and Anal Cancer Foundation’s latest activities and events.
We are excited to announce our 2022 webinar series! When you know what your providers know, you are empowered to have more in-depth and productive conversations toward our #1 priority: getting you the best care possible. Building from the success of our virtual anal cancer conference in 2021, we want to bring the experts right… read more
Today, Anal Cancer Foundation Scientific Advisory Board Member Dr. Joel Palefsky presented the Anal Cancer HSIL Outcomes Research (ANCHOR) study results at the prestigious CROI 2022 conference. We learned that early detection and treatment of anal HSIL (anal precancer) reduces cancer progression by 57%. “After 10 years of fighting for better prevention for anal cancer… read more
ACF co-founder Tristan Almada and Jill Bourdais, a peer in our support program, quoted in WebMD. Read the article